Brokerages Set Progyny, Inc. (NASDAQ:PGNY) Price Target at $23.64

Shares of Progyny, Inc. (NASDAQ:PGNY - Get Free Report) have been given an average rating of "Hold" by the thirteen analysts that are covering the firm, Marketbeat reports. Eight equities research analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $23.64.

A number of research firms have recently issued reports on PGNY. JPMorgan Chase & Co. boosted their price objective on Progyny from $17.00 to $23.00 and gave the company a "neutral" rating in a research report on Tuesday, January 28th. Canaccord Genuity Group lifted their price target on shares of Progyny from $17.00 to $23.00 and gave the stock a "hold" rating in a research note on Friday, February 28th. BTIG Research upgraded shares of Progyny from a "neutral" rating to a "buy" rating and set a $28.00 price objective for the company in a research note on Monday, March 31st. Finally, Bank of America lifted their target price on shares of Progyny from $21.00 to $25.00 and gave the company a "buy" rating in a research report on Tuesday, February 11th.

Progyny Trading Up 0.2 %

PGNY traded up $0.04 on Monday, hitting $21.44. 1,236,518 shares of the stock traded hands, compared to its average volume of 1,741,105. The business has a fifty day moving average price of $21.94 and a two-hundred day moving average price of $18.84. The firm has a market capitalization of $1.84 billion, a PE ratio of 36.97, a P/E/G ratio of 2.39 and a beta of 1.33. Progyny has a 52 week low of $13.39 and a 52 week high of $33.84.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of the company. Wealth Enhancement Advisory Services LLC bought a new stake in Progyny during the 1st quarter worth approximately $354,000. GAMMA Investing LLC grew its holdings in shares of Progyny by 233.9% during the first quarter. GAMMA Investing LLC now owns 5,379 shares of the company's stock worth $120,000 after purchasing an additional 3,768 shares during the last quarter. Olstein Capital Management L.P. bought a new stake in shares of Progyny during the first quarter worth $469,000. NBC Securities Inc. increased its stake in shares of Progyny by 97,037.5% in the first quarter. NBC Securities Inc. now owns 23,313 shares of the company's stock valued at $520,000 after buying an additional 23,289 shares in the last quarter. Finally, Mackenzie Financial Corp raised its holdings in shares of Progyny by 423.8% in the fourth quarter. Mackenzie Financial Corp now owns 117,387 shares of the company's stock valued at $2,025,000 after buying an additional 94,978 shares during the last quarter. Institutional investors own 94.93% of the company's stock.

About Progyny

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.